Navegar

Colección

Datos Estadísticas

Lista de

Parkinson's disease
22
"Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein" (2018) Martinez, J.H.;Alaimo, A.;Gorojod, R.M. (...)Kotler, M.L. Molecular and Cellular Neuroscience. 88:107-117
"Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment" (2018) Martínez, J.H.;Fuentes, F.;Vanasco, V. (...)Velazquez, F. Archives of Biochemistry and Biophysics. 651:1-12
"Bottom-up gamma maintenance in various disorders" (2018) Garcia-Rill, E.; Mahaffey, S.; Hyde, J.R.; Urbano, F.J. Neurobiology of Disease
"How language flows when movements don't: An automated analysis of spontaneous discourse in Parkinson's disease" (2016) García, A.M.;Carrillo, F.;Orozco-Arroyave, J.R. (...)Cecchi, G.A. Brain and Language. 162:19-28
"Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals" (2012) Borsarelli, C.D.;Falomir-Lockhart, L.J.;Ostatná, V. (...)Jovin, T.M. Free Radical Biology and Medicine. 53(4):1004-1015
"FRET imaging by kt/kf" (2011) Roberti, M.J.; Giordano, L.; Jovin, T.M.; Jares-Erijman, E.A. ChemPhysChem. 12(3):563-566
"Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells" (2009) Roberti, M.J.;Morgan, M.;Menéndez, G. (...)Jares-Erijman, E.A. Journal of the American Chemical Society. 131(23):8102-8107
"Interplay of multivalency and optical properties of quantum dots: Implications for sensing and actuation in living cells" (2009) Menéndez, G.;Roberti, M.J.;Sigot, V. (...)Erijman, J.E.A. Colloidal Quantum Dots for Biomedical Applications IV. 7189
"Interplay of multivalency and optical properties of quantum dots: Implications for sensing and actuation in living cells" (2009) Menéndez, G.;Roberti, M.J.;Sigot, V. (...)Erijman, J.E.A. Colloidal Quantum Dots for Biomedical Applications IV. 7189
"Multiparametric Fluorescence Detection of Early Stages in the Amyloid Protein Aggregation of Pyrene-labeled α-Synuclein" (2008) Thirunavukkuarasu, S.; Jares-Erijman, E.A.; Jovin, T.M. Journal of Molecular Biology. 378(5):1064-1073
"NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation" (2004) Fernández, C.O.;Hoyer, W.;Zweckstetter, M. (...)Jovin, T.M. EMBO Journal. 23(10):2039-2046
"Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients" (2001) Serra, J.A.;Domínguez, R.O.;De Lustig, E.S. (...)Marschoff, E.R. Journal of Neural Transmission. 108(10):1135-1148
"The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice" (2000) Murer, M.G.;Dziewczapolski, G.;Salin, P. (...)Gershanik, O. Neuroscience. 99(4):643-650
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276
"Dysthymia in neurological disorders" (1996) Akiskal, H.S.;Bolis, C.L.;Cazzullo, C. (...)Wong, M.-L. Molecular Psychiatry. 1(6):478-491
"Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia" (1996) Starkstem, S.E.;Sabe, L.;Petracca, G. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 61(4):381-387
"Catatonia in depression: Prevalence, clinical correlates, and validation of a scale" (1996) Starkstein, S.E.;Petracca, G.;Tesón, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 60(3):326-332
"Adynamic bowel syndrome in Parkinson's disease with dramatic response to apomorphine" (1994) Merello, M.; Leiguarda, R. Clinical Neuropharmacology. 17(6):574-577